CONCORD, New Hampshire (The Adobo Chronicles) – Despite his second-place finish in last week’s Iowa Caucuses, Republican presidential candidate Donald Trump is confident he will win his party’s nomination for the 2016 elections.  To reinforce his confidence, he has named his vice presidential running mate.  Martin Shkreli.

Shkreli is an American entrepreneur and financial and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin LLC, and founder and former CEO of Turing Pharmaceuticals AG. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by 5,556 percent (from US$13.50 to US$750 per tablet).

On December 17, 2015, Shkreli was arrested by the FBI on charges of securities fraud and released on bail.

This week, Shkreli testified before Congress and his performance impressed The Donald.

“I like this guy. He is not intimidated by anyone, not even by members of Congress.  Just like me,” Trump said.

Today in New Hampshire, while campaigning for next week’s primary, Trump officially named Shkreli as his VP running mate, saying that the “pharma bro” exudes the kind of tough, shrewd, fearless Washington outsider that  America needs to make the country great again. “He even has the same smirk as I do,” Trump added.

Birds of the same feather flock together.